The National Immunization Program of the Centers for Disease Control and Prevention (CDC) asked the Institute of Medicine (IOM) to review current immunization financing and then develop strategies that improve the way vaccines are purchased and distributed in the U.S. health care system. As a first step, the committee examined the societal benefits of vaccines, the scope of government investment, and emerging problems of the current financing approach.